Cell cycle-specific proteolysis involves the addition of Entry into mitosis is triggered by the activated cyclin ubiquitin molecules along a cascade of E1, E2, and E3
B1/Cdk1 complex (also known as M-phase-promoting enzymes to target proteins, thus marking them for degfactor or MPF), the activity of which must be exquisitely radation by the proteasome (Hochstrasser, 1996) . The controlled during the cell cycle (Minshull et al., 1989 ). E3 ubiquitin-protein ligases are critical in these ubiquitiIn the course of mitosis, cyclin B1 is targeted for ubiqnation reactions, as they allow the transfer of activated uitination by the APC in anaphase to allow for subseubiquitin from E2 enzymes to the target protein and mequent mitotic exit (King et al., 1995 ; Zachariae and diate the specificity of substrate recognition (WeissNasmyth, 1999). Tight control of MPF activity is particuman, 2001). Two types of E3 ligase complexes are larly important during interphase, since untimely activaprominent in controlling the abundance of cell cycle tion can trigger premature mitotic entry, thereby comregulatory proteins: the APC and the SCF. The APC promising the fidelity of genome replication. Nuclear (anaphase-promoting complex) is a multisubunit comabundance of cyclin B1 is a major determinant of MPF plex that targets substrates for degradation only during activity, thus necessitating regulatory means for timing mitosis and G1 and is responsible for targeting mitotic of the subcellular localization of this cyclin. The precyclins and proteins involved in sister chromatid cohedominant cytoplasmic localization of cyclin B1, which sion and spindle function (Zachariae and Nasmyth, is reversed only upon phosphorylation of the CRS (cy-1999). More recently, the SCF class of E3 ubiquitin litoplasmic retention signal) region, and the switchlike upregulation of Cdk1-cyclin B1 activity in response to an increase in cyclin B1 concentration have emerged Yang et al., 1998). In addition, the impact of nuclear cyclin B1 has recently broadened with the identification for the endogenous NIPA protein. As shown in Figure  1E , the NIPA antibody detects a protein of the expected of its S-phase-promoting potential (Moore et al., 2003) . Therefore, identification of the mechanisms that control molecular mass (66 kDa) in HeLa cells. The antibody was only reactive toward the human NIPA protein and cyclin B1 expression and function spatially and temporally are crucial for understanding DNA replication and did not detect the murine homolog in NIH 3T3 cells. When applied to indirect immunofluorescence in HeLa the timing of mitotic entry.
Recently, we identified NIPA (nuclear interaction partcells, the NIPA antiserum detected NIPA exclusively in the nucleus ( Figure 1E ). As observed with overexner of ALK) as a protein of widespread expression and exclusive nuclear subcellular location in a screen to pressed NIPA ( Figure 1A ), endogenous NIPA became abundant in S phase and was phosphorylated at G 2 /M identify phosphotyrosine-dependent interaction partners of the activated anaplastic lymphoma kinase (ALK) ( Figure 1F Since many proteins known to associate with Skp1 during interphase only. In addition to the well-known are F-box proteins, we searched for an F-box motif in APC-mediated degradation of cyclin B1 in mitosis, our the NIPA sequence. Close examination of this sequence data suggest an SCF-based ubiquitination process inrevealed an F-box motif in the N terminus of the NIPA volving cyclin B1 in interphase, thereby providing a mechprotein (amino acids 170-210) ( Figure 2B ). Mutation of anism to inhibit premature nuclear accumulation of the core LP residues (L170 and P171) of the NIPA F-box cyclin B1 during the mammalian cell cycle.
abolished binding to Skp1, thus identifying this motif as the relevant binding region and suggesting that NIPA is a human F-box-containing protein (Figure 2A ). AddiResults tionally, we identified binding determinants for NIPA in both the N and C termini of Skp1, which is thought to Cell-Cycle-Dependent Expression be typical for the Skp1-F-box interaction (data not and Phosphorylation of NIPA shown) (Ng et al., 1998). We initially isolated NIPA as a human nuclear protein in a screen for activated ALK binding proteins (Ouyang et al., 2003) . In an effort to determine whether NIPA plays NIPA Is Part of a Functionally Active SCF Complex that Assembles in a Cell-Cycle-Regulated Manner a role in cell cycle control, we assayed for modifications of the protein throughout the mammalian cell cycle.
Since we confirmed that NIPA interacts with Skp1 and that this interaction requires a functional F-box motif, NIPA expression was minimal in growth-arrested cells (G 0/1 ) and became abundant in S and G 2 /M phases (Fig- we examined whether NIPA assembles with the other known mammalian SCF subunits (Cul1, Roc1) to form ure 1A). Moreover, the apparent molecular mass of NIPA was increased in G 2 /M cells ( Figure 1A ). This moan SCF complex. To test for in vivo complex formation, we precipitated Flag-NIPA from 293T cell lysates transbility shift was sensitive to phosphatase treatment and thus most likely due to phosphorylation ( Figure 1B ). To fected with the constructs indicated ( Figure 3A) . As depicted in this figure, NIPA copurified with Skp1, Cul1, assess NIPA levels and phosphorylation in the ongoing cell cycle, we released synchronized cells from either S and Roc1 to form a complete SCF complex. Complex formation was also found to occur in vitro using a cellphase or the G 2 /M boundary and assayed for expression and phosphorylation of the protein. As depicted free system, thus suggesting direct interaction (Figure 3B ). in Figure 1C , NIPA phosphorylation increased as cells approached G 2 /M. Analysis of the cell cycle phase tranHaving shown that NIPA can form an SCF complex (SCF NIPA ), we next determined whether SCF NIPA possition times of the NIH 3T3 cells used suggested an onset of NIPA phosphorylation in G2 phase, with a peak sesses associated ubiquitination-promoting activity. As shown in Figure 3C , increased ubiquitination-promoting at the G 2 /M boundary. After the G 2 /M transition, NIPA phosphorylation and expression levels declined precipactivity was observed after preincubation of GST-NIPA with extracts derived from cells transfected with the itously upon reentry into G 1 ( Figure 1C, right panel) . Using tryptic phosphopeptide analysis combined with SCF core components Skp1, Cul1, and Roc1 (+SCF) ( Figure 3C, compare lanes 3 and 4) . When preincubated the engineering of mutations of candidate phosphorylation sites, we determined that serine 354 is a major with untransfected extracts (−SCF) (lane 7) or not preincubated (lane 2), GST-NIPA exhibited only background phosphorylation site during the course of cell-cycledependent phosphorylation of NIPA ( Figure 1D) . activity, similar to GST alone (lane 1). These findings suggest that SCF NIPA contains ubiquitin ligase activity We next generated polyclonal murine NIPA antibodies to demonstrate that these cell cycle effects are valid and interacts with the ubiquitination machinery. We reasoned that the cell-cycle-dependent phosinterphase cells and was not detectable in G 2 /M cells ( Figure 3E ). Thus, cell-cycle-dependent phosphorylaphorylation of NIPA from G 2 phase through mitosis (see We next carried out an in vitro ubiquitination assay using HeLa extracts that were either NIPA inactivated nuclear cyclin B1 levels in interphase cells to increase upon inhibition of the proteasome ( Figure 4B ). Thus, we or reconstituted with purified protein to further investigate the requirement of NIPA for cyclin B1 ubiquitinainvestigated whether NIPA can interact with cyclin B1. We precipitated cyclin B1 from either interphase cells tion. NIPA inactivation was performed using an siRNA approach ( Figure We used an siRNA knockdown approach to further assess the role of SCF NIPA in controlling the nuclear abun-SCF NIPA-S354A complex, was included in the assay. Cyclin B1 was immunoprecipitated from nuclear cell dance of cyclin B1. On both the RNA and protein levels, a significant reduction of NIPA expression was obextracts expressing the plasmids indicated in Figure  4H . In interphase cells, expression of both NIPA wt and served upon NIPA siRNA treatment ( Figure 5A ). Silencing of NIPA caused a considerable accumulation of NIPA S354A stimulated ubiquitination of cyclin B1 (Figure 4H, lanes 2 and 3) . However, when cyclin B1 precipcyclin B1 protein in nuclear extracts as compared to cells transfected with control siRNA ( Figure 5A , right itated from G 2 /M cells was examined, ubiquitination of the cyclin protein was observed only in the NIPA S354A panel), whereas, on the RNA level, cyclin B1 was not affected ( Figure 5A , left panel). We then tested the efsample (lanes 6 and 7). Notably, essentially no ubiquitination of cyclin B1 was observed when the cyclin B1 fect of silencing NIPA expression in HeLa cells arrested in S phase. Cells were synchronized by thymidine treatprotein precipitated from the corresponding cytoplasmic cell extracts was examined (data not shown). Thus, ment, and pulse-chase analysis was performed. Nuclear cyclin B1 was degraded in cells transfected with connuclear cyclin B1 is targeted for ubiquitination by the SCF NIPA complex in interphase only, whereas the trol siRNA, whereas the levels of nuclear cyclin B1 remained constant in cells treated with NIPA siRNA (Fig-SCF NIPA-S354A complex remains constitutively active and targets nuclear cyclin B1 throughout G 2 /M.
ure 5B). 5-8) or left unsynchronized (lanes 1-4) . Following treatment with LLnL, nuclear extracts were prepared and subjected to cyclin B1 immunoprecipitation.
We reasoned that nuclear accumulation of cyclin B1 mit synchronized cell cycle progression. Using 2D cell cycle analysis, an evident delay of mitotic entry was evoked by NIPA inactivation might affect the timing of mitotic entry. First, we determined the effect of NIPA observed in cells expressing the phosphorylation-deficient NIPA S354A mutant as compared to NIPA wt-or inactivation on the cyclin B1/Cdk1 kinase activity using a histone H1 kinase assay. As depicted in Figure 5C , vector-containing cells ( Figure 6C ). To rule out that this observation was the result of a proapoptotic effect of cyclin B1-associated kinase activity in cells released from G 1 /S peaked significantly earlier in NIPA knock-NIPA S354A, we applied TUNEL analysis to the inducible cell lines used and found no induction of apoptosis down cells (5 hr) as compared to control cells (10 hr). Furthermore, kinase activity in NIPA knockdown cells in the respective cells ( Figure 6B, right panel) . Immunofluorescence microscopy revealed that the apparent remained at high levels throughout the period under observation. Next, we examined the kinetics of mitotic delay of NIPA S354A cells occurred at an early stage of mitotic entry (prophase), given that nuclear envelope entry in cells released from G 1 /S using phosphorylation of histone H3 as a mitotic marker. Premature mitotic breakdown had not yet occurred ( Figure 6D ) and histone H3 phosphorylation was not yet detectable (data entry was clearly observed in NIPA knockdown cells, while control cells displayed a physiological course of not shown).
To correlate the extent of delay at mitotic entry to the mitotic entry ( Figure 5D ). Of note, NIPA knockdown cells remained in mitosis longer than the corresponding expression level of NIPA S354A in terms of a doseeffect relationship, we generated single cell-derived control cells ( Figure 5D mechanism explaining how the cell is protected from In this report, we show that cell-cycle-dependent premature nuclear accumulation of cyclin B1 and, thus, phosphorylation of an F-box protein, NIPA, acts as a premature mitotic entry: proteolytic degradation during timing circuit for the activity of its corresponding SCF interphase based on SCF-mediated ubiquitination. Precomplex. This mechanism may represent a more genviously, ubiquitination as a means of cyclin B1 regulaeral principle to regulate SCF activity. Subsequent to tion had been demonstrated only in mitosis, mediated the NIPA phosphorylation event at G 2 /M, we observed by the APC ubiquitin ligase (Zachariae and Nasmyth, expression levels of NIPA to decline as cells exited mi-1999). Our data suggest a dual mode of degradation for tosis and entered G1. Therefore, phosphorylated NIPA cyclin B1 involving the SCF NIPA complex during inmay be a substrate for proteosomal degradation itself. terphase in addition to the known APC activity in mitoWhile we have not identified the serine/threonine kisis. Cooperation and interdependent activity of the APC nase(s) responsible for NIPA phosphorylation as yet, it and SCF E3 ubiquitin ligases may be a more general is intriguing to speculate that such a kinase could be oscillation mechanism in the control of cell-cyclestimulated apart from its physiologic cell-cycle-dependependent protein abundance. In this regard, a recent dent activation by oncogenic tyrosine kinases as well.
report has described a similar mechanism involving the As previously reported, we cloned NIPA in complex with APC and SCF for ubiquitin-mediated degradation of the oncogenic tyrosine kinase NPM-ALK and deterhuman Cdc25a ( -phospho-H3) .
SCF System
To assay in vitro ubiquitination of cyclin B1 using a reconstituted Antibody Preparation system, purified GST-cyclin B1 (Upstate) was collected on glutathiBacterially produced GST-NIPA (BL-21 cells) was used to raise one-agarose beads and preincubated with HeLa lysate. GST-cyclin polyclonal antibodies in mice (Davids Biotechnology, Regensburg, B1 was subsequently precipitated and washed three times in lysis Germany). The resulting serum was affinity purified.
buffer and ubiquitination buffer (40 mM Tris-HCl [pH 7.6], 5 mM MgCl 2 , 1 mM DTT, 10% glycerol). Thereafter, GST-cyclin B1 was Yeast Two-Hybrid System transferred to the ubiquitination reactions, which contained apThe full-length NIPA cDNA was cloned into the yeast expression proximately 500 ng each of purified Skp1-NIPA or Skp1-Cdc4 vector pBTM116 for use as the bait to screen a human testis library together with Cul1-Roc1 complexes, 0.5 g/µl ubiquitin, 1 g E1 (Clontech) (9 × 10 6 clones) in the Saccharomyces cerevisiae L40 (Affinity, Inc.), 1.3 g CDC34 (A.G. Scientific, Inc.), 10 mM phosphostrain, as previously described (Bai et al., 2002) . creatine, 100 g/ml creatine phosphokinase, 0.5 mM ATP, and 1 M ubiquitin aldehyde. was centrifuged at 10,000 × g for 10 min to obtain the S10 super-M quercetin for 16 hr at 37°C to arrest them in S phase or were natant. arrested at G 2 /M by sequential culture with 2 mM thymidine and 500 ng/ml nocodazole. For synchronization in G 0/1 , cells were serum starved for 48 hr (0.5% FCS). Synchronization at G 1 /S was In Vitro Ubiquitination and Degradation Assay performed using a double thymidine block.
The ubiquitination reaction mix contained 0.5 g/µl ubiquitin, 1 M ubiquitin aldehyde, 10 mM phosphocreatine, 100 g/ml creatine Cell Cycle Analysis phosphokinase, 0.5 mM ATP, 20 g HeLa extract, and 100 ng puriFor BrdU incorporation and DNA content analysis, cells were fied GST-cyclin B1 in ubiquitination buffer. Baculovirus-produced pulsed with 10 M BrdU (BD Biosciences) for 40 min and subseSkp1-NIPA or Skp1-Skp2 was added in similar amounts, as indiquently stained according to a standard protocol. One-and twocated. dimensional flow cytometry was performed to detect either PI or The cyclin B1 degradation assay was performed in a similar manboth fluorescein and PI. To quantify cell cycle distribution, the ner, except that proteasome inhibitors, ubiquitin, and ubiquitin alFlowJo software (Tree Star Inc., Stamford, Connecticut) was utidehyde were omitted and extracts were prepared as described in lized.
Carrano et al. [1999] . tone H3[S10-P]) were used at dilutions of 1:1000, 1:400, and 1:200, reMnCl 2 , 100 g/ml BSA, 50 M leupeptin) using potato acid phosspectively. phatase, type III (Sigma) at 100 g/ml.
Northern Blotting and Quantitative PCR Total RNA was extracted from HeLa cells using Trizol reagent (Invi
